Mott is fourth in the country for heart surgery, ranked among the best nationwide in all 10 evaluated pediatric specialties
Cockeysville Doctor To Jump Off 25-Story Building – Patch.com
Cockeysville Doctor To Jump Off 25-Story BuildingPatch.comCockeysville resident Matt Cooper, who is also the director of kidney transplantation at Georgetown University, is participating in the third annual Rappel for Kidney Health fundraiser. "It…
Scripps Health part of first intercontinental kidney transplant chain
Scripps Health patients and doctors made history by participating in the first intercontinental kidney transplant paired donor chain, which started with a man in Greece and has grown to involve 10 organ donors and recipients.
Scripps Health part of first intercontinental kidney transplant chain – La Jolla Light
Scripps Health part of first intercontinental kidney transplant chainLa Jolla Light“This is a new and exciting era in organ transplantation,” said Christopher Marsh, MD, chief of transplant surgery at Scripps Green. “I hope this example motivates…
Surgeon: Remove Kidneys for Transplant Before Donor's Death
Proposed Protocol: Remove Kidneys for Transplant if Donors' Death Is Imminent
SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical … – Healthcare Global (press release)
SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical …Healthcare Global (press release)SymBio Announces Results Presented at ASCO 2012 Evaluating Clinical Benefits of TREAKISYM(R) (Bendamustine) in Combination With Rituximab in Patient…
Preemptive Transplants May Not Offer Survival Edge – Renal and Urology News
Preemptive Transplants May Not Offer Survival EdgeRenal and Urology NewsBOSTON—Preemptive kidney transplantation may offer no survival advantage over kidney transplantation soon after dialysis initiation, according to new findings reported at the 201…
Bone marrow transplant drug a step closer
DRUG that stops the body from rejecting bone marrow transplants in cancer patients could be ready for human trials in three years.
New Treatment Option for Non-Hodgkin Lymphoma Delays Tumour Progression With … – MarketWatch (press release)
New Treatment Option for Non-Hodgkin Lymphoma Delays Tumour Progression With …MarketWatch (press release)A trial that enrolled 549 patients with certain types of immune system cancers showed that bendamustine and rituximab worked better and was less …
Bristol-Myers Squibb Presents New 4-Year Data from the Long-Term Extensions … – PipelineReview.com (press release)
Bristol-Myers Squibb Presents New 4-Year Data from the Long-Term Extensions …PipelineReview.com (press release)Both patient groups received basiliximab induction, MMF and corticosteroids. Both studies excluded recipients undergoing first transplant w…